All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 6, 2022

Genomics

Home » Topics » Diagnostics » Genomics
  • Red blood cells2
    June 3, 2022
    By Nuala Moran

    Long in the making changes lead to tipping point in blood stem cells

    Two studies published back to back in Nature have looked at the accumulation of mutations in blood-forming stem cells with age, gaining new insights into how the overall landscape of such cells changes across the lifespan. 
  • Dna sequence and covid 19 infection virus cells
    March 7, 2022
    By Nuala Moran

    Study finds variants that increase risk of severe COVID-19

    The world’s largest genomics study in patients with life-threatening COVID-19 infections has uncovered 16 new genetic variants associated with severe disease and drawn up a roadmap for research into new therapies and diagnostics. The research involved comparing the complete genome sequences of 7,491 patients admitted to 224 intensive care units in the U.K. against those of 48,400 participants in Genomics England’s 100,000 Genomes project, and of a further 1,630 people who had mild COVID-19. While some of the gene variants found in the Genomicc study affect the function of a protein, others influence the amount of the protein that is expressed. An example is mucin-1, where overexpression led to worse outcomes.
  • 02 02 biofidelity staff
    Feb. 2, 2022
    By Catherine Longworth

    Biofidelity attracts $23M series A investment to launch lung cancer test

    Cancer diagnostics company Biofidelity Ltd. reported a $23 million series A+ investment round, led by Octopus Ventures with participation from SBI Investment Co. Ltd. and existing investors. Funds will be used for the commercial launch of the company’s first commercial assay Asypre-Lung. The oncology panel is designed to detect DNA mutations from tissue or liquid biopsy quicker than current approaches like gene sequencing.
Read More

Blog Posts

  • March 27, 2015
    By Michael Fitzhugh

    Sharing deeply of ourselves: Still messy

  • March 4, 2014
    By Anette Breindl

    Human germline engineering: The mom’s not in the picture

  • Aug. 9, 2013
    By Randy Osborne

    Spittin’ Image: Or, How I Am Probably Going to Die

  • Jan. 17, 2013
    By Anette Breindl

    DNA Donor Anonymity: for the Lucky Few?

  • July 6, 2012
    By Marie Powers

    BioWorld's Biotech Summer Reading List Plumbs the Classics, BioEthics & Life's Simple Pleasures

Read More

Authors

  • Anette Breindl
  • Marie Powers
  • Randy Osborne
  • Michael Fitzhugh
  • Jihyun Kim
  • Tamra Sami
More Authors
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing